The role of MYOG in a FN-RMS CRC is perplexing, as many proposed mechanisms for maintenance of FN-RMS tumors in a proliferative state involve inhibiting MYOD1’s ability to transactivate MYOG. Here, FN1 is linked to colorectal carcinoma.